Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitsuhiro Ito

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Vaccines|February 26, 2022
The Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Japanese Patients after Allogeneic Stem Cell TransplantationMarika Watanabe, Kimikazu Yakushijin, Yohei Funakoshi, et al.
International Journal of Hematology|March 17, 2026
Clinical hepatic indices serve as predictive markers for sinusoidal obstruction syndrome after allogeneic HSCTHiroya Ichikawa, Kimikazu Yakushijin, Yumiko Inui, et al.
Ejhaem|August 19, 2024
Analysis of B-cell receptor repertoire to evaluate immunogenicity of monovalent Omicron XBB.1.5 mRNA vaccinesYohei Funakoshi, Kimikazu Yakushijin, Goh Ohji, et al.
International Journal of Hematology|March 24, 2018
Early lymphocyte recovery predicts clinical outcome after HSCT with mycophenolate mofetil prophylaxis in the Japanese populationKeiji Kurata, Kimikazu Yakushijin, Ishikazu Mizuno, et al.
Internal Medicine (Tokyo, Japan)|November 20, 2018
Successful Bridging Chemotherapy with Gemcitabine, Carboplatin, and Dexamethasone before Unrelated Stem Cell Transplantation for Hepatosplenic T-cell LymphomaMarika Okuni, Kimikazu Yakushijin, Keiichiro Uehara, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 11, 2018
Human herpesvirus 6 encephalitis in patients administered mycophenolate mofetil as prophylaxis for graft-versus-host disease after allogeneic hematopoietic stem cell transplantationYumiko Inui, Kimikazu Yakushijin, Atsuo Okamura, et al.
ACS Medicinal Chemistry Letters|March 17, 2022
Discovery of TAK-925 as a Potent, Selective, and Brain-Penetrant Orexin 2 Receptor AgonistTatsuhiko Fujimoto, Kentaro Rikimaru, Koichiro Fukuda, et al.
International Journal of Hematology|September 11, 2016
A prospective study of the antiemetic effect of palonosetron in malignant lymphoma patients treated with the CHOP regimenYoshiharu Miyata, Kimikazu Yakushijin, Yumiko Inui, et al.
Ejhaem|February 23, 2023
Global longitudinal strain is superior to ejection fraction for long-term follow-up after allogeneic hematopoietic stem cell transplantationMarika Watanabe, Kimikazu Yakushijin, Hidekazu Tanaka, et al.
Vaccines|November 11, 2022
A Third Dose COVID-19 Vaccination in Allogeneic Hematopoietic Stem Cell Transplantation PatientsMarika Watanabe, Kimikazu Yakushijin, Yohei Funakoshi, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Vaccines|February 26, 2022
The Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Japanese Patients after Allogeneic Stem Cell TransplantationMarika Watanabe, Kimikazu Yakushijin, Yohei Funakoshi, et al.
International Journal of Hematology|March 17, 2026
Clinical hepatic indices serve as predictive markers for sinusoidal obstruction syndrome after allogeneic HSCTHiroya Ichikawa, Kimikazu Yakushijin, Yumiko Inui, et al.
Ejhaem|August 19, 2024
Analysis of B-cell receptor repertoire to evaluate immunogenicity of monovalent Omicron XBB.1.5 mRNA vaccinesYohei Funakoshi, Kimikazu Yakushijin, Goh Ohji, et al.
International Journal of Hematology|March 24, 2018
Early lymphocyte recovery predicts clinical outcome after HSCT with mycophenolate mofetil prophylaxis in the Japanese populationKeiji Kurata, Kimikazu Yakushijin, Ishikazu Mizuno, et al.
Internal Medicine (Tokyo, Japan)|November 20, 2018
Successful Bridging Chemotherapy with Gemcitabine, Carboplatin, and Dexamethasone before Unrelated Stem Cell Transplantation for Hepatosplenic T-cell LymphomaMarika Okuni, Kimikazu Yakushijin, Keiichiro Uehara, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 11, 2018
Human herpesvirus 6 encephalitis in patients administered mycophenolate mofetil as prophylaxis for graft-versus-host disease after allogeneic hematopoietic stem cell transplantationYumiko Inui, Kimikazu Yakushijin, Atsuo Okamura, et al.
ACS Medicinal Chemistry Letters|March 17, 2022
Discovery of TAK-925 as a Potent, Selective, and Brain-Penetrant Orexin 2 Receptor AgonistTatsuhiko Fujimoto, Kentaro Rikimaru, Koichiro Fukuda, et al.
International Journal of Hematology|September 11, 2016
A prospective study of the antiemetic effect of palonosetron in malignant lymphoma patients treated with the CHOP regimenYoshiharu Miyata, Kimikazu Yakushijin, Yumiko Inui, et al.
Ejhaem|February 23, 2023
Global longitudinal strain is superior to ejection fraction for long-term follow-up after allogeneic hematopoietic stem cell transplantationMarika Watanabe, Kimikazu Yakushijin, Hidekazu Tanaka, et al.
Vaccines|November 11, 2022
A Third Dose COVID-19 Vaccination in Allogeneic Hematopoietic Stem Cell Transplantation PatientsMarika Watanabe, Kimikazu Yakushijin, Yohei Funakoshi, et al.
Pageof 9